Literature DB >> 8514456

The effects of tumour necrosis factor alpha on the vascular bed and blood flow in an experimental rat hepatoma.

P L Naredi1, P G Lindnér, S B Holmberg, U Stenram, A Peterson, L R Hafström.   

Abstract

The influence of TNF alpha on tumour growth rate has been attributed to its effects on the vascular bed and blood flow. The aim of our study was to investigate the effects of pharmacological doses of TNF alpha on the tumour vascular bed and to quantify blood flow in an experimental hepatoma during a more extended period after TNF-alpha exposure than hitherto reported. In Lister rats, a syngeneic rat hepatoma was implanted on the dorsum of the right hind foot. TNF alpha was given i.v. The injection was repeated after 24 hr. Tumour blood flow was estimated before and 1, 24, and 96 hr after TNF-alpha administration with the 133Xe-washout technique. The passage of microspheres through the tumour vascular bed (non-entrapment), as a measure of vascular occlusion, was estimated 4 and 96 hr after TNF-alpha administration. Tumour growth rate was measured. The tumours were subjected to histological examination and the sensitivity to TNF alpha in vitro was tested. A reduction of tumour blood flow was observed in TNF-alpha-treated groups. Tumour growth rate was equally increased after 96 hr in both the TNF-alpha groups as compared with controls. There was no significant change in non-entrapment for the TNF-alpha-treated rats as compared with controls. Histology revealed extensive necrosis and thrombosis in tumours. TNF alpha had no effect on the viability of the cloned hepatoma cell line in vitro.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514456     DOI: 10.1002/ijc.2910540420

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

Review 1.  TNF-α, a good or bad factor in hematological diseases?

Authors:  Tian Tian; Min Wang; Daoxin Ma
Journal:  Stem Cell Investig       Date:  2014-06-01

2.  Synergistic antitumor effect of an angiogenesis inhibitor (TNP-470) and tumor necrosis factor in mice.

Authors:  Katsumi Amikura; Seiki Matsuno; Shinichi Egawa
Journal:  Surg Today       Date:  2006-12-25       Impact factor: 2.549

3.  Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results.

Authors:  Joseph M Herman; Aaron T Wild; Hao Wang; Phuoc T Tran; Kenneth J Chang; Gretchen E Taylor; Ross C Donehower; Timothy M Pawlik; Mark A Ziegler; Hongyan Cai; Dionne T Savage; Marcia I Canto; Jason Klapman; Tony Reid; Raj J Shah; Sarah E Hoffe; Alexander Rosemurgy; Christopher L Wolfgang; Daniel A Laheru
Journal:  J Clin Oncol       Date:  2013-01-22       Impact factor: 44.544

4.  Noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma using xenon-enhanced computed tomography.

Authors:  Junzo Shimizu; Hiroshi Oka; Keizo Dono; Masato Sakon; Manabu Takamura; Takamichi Murakami; Shouho Hayashi; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Shigeru Sase; Mitsukazu Gotoh; Kenichi Wakasa; Hironobu Nakamura; Morito Monden
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

5.  Stable bioenergetic status despite substantial changes in blood flow and tissue oxygenation in a rat tumour.

Authors:  P Vaupel; D K Kelleher; T Engel
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.